Are we repeating the statin playbook with lipoprotein(a)?

Are we repeating the statin playbook with lipoprotein(a)?

In the late 1970s, a Japanese biochemist named Akira Endo discovered a compound from fungus that inhibited HMG-CoA reductase, the enzyme responsible for making cholesterol. It was an academic curiosity at the time. No one knew if lowering cholesterol would prevent heart attacks—it just lowered a number on a lab slip. That compound eventually became Read more… Are we repeating the statin playbook with lipoprotein(a)? originally appeared in KevinM…